tiprankstipranks
Trending News
More News >
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Compare Beam Therapeutics (BEAM) vs. Competitors

Compare
2,108 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Beam Therapeutics
$28.93
$2.88B
-6.52
6.83%
11 Buy
3 Hold
0 Sell
Strong Buy
Denali Therapeutics
$16.95
$2.69B
-5.82
-19.97%
13 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$26.73
$5.22B
-9.45
8.48%
7 Buy
2 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$29.58
$3.58B
-83.44
87.69%
7 Buy
1 Hold
0 Sell
Strong Buy
Disc Medicine
$80.94
$2.92B
-15.11
30.55%
13 Buy
0 Hold
0 Sell
Strong Buy
Immunocore Holdings
$33.76
$1.66B
-57.79
9.54%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BEAM
Beam Therapeutics
28.93
2.54
9.62%
DNLI
Denali Therapeutics
16.95
-2.15
-11.26%
IMVT
Immunovant
26.73
3.25
13.84%
ARQT
Arcutis Biotherapeutics
29.58
15.77
114.19%
IRON
Disc Medicine
80.94
21.70
36.63%
IMCR
Immunocore Holdings
33.76
3.36
11.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts